PEBP2-β/CBF-β-dependent phosphorylation of RUNX1 and p300 by HIPK2 : implications for leukemogenesisWEE, Hee-Jun; VOON, Dominic Chih-Cheng; BAE, Suk-Chul et al.Blood. 2008, Vol 112, Num 9, pp 3777-3787, issn 0006-4971, 11 p.Article

RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiencyKAUR, Gurpreet; JALAGADUGULA, Gauthami; GUANGFEN MAO et al.Blood. 2010, Vol 115, Num 15, pp 3128-3135, issn 0006-4971, 8 p.Article

Core Binding Factor Acute Myeloid LeukemiaPASCHKA, Peter.Seminars in oncology. 2008, Vol 35, Num 4, pp 410-417, issn 0093-7754, 8 p.Article

Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification. CommentaryNUTT, Stephen L; YALIN GUO; MAILLARD, Ivan et al.Blood. 2008, Vol 112, Num 3, issn 0006-4971, 454, 480-492 [14 p.]Article

CBF reactivity in hypotensive and normotensive preterm infantsJAYASINGHE, Dulip; GILL, A. Bryan; LEVENE, Malcolm I et al.Pediatric research. 2003, Vol 54, Num 6, pp 848-853, issn 0031-3998, 6 p.Article

A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemiaHUH, Jungwon; KIM, Hee-Je; SUNG HYUN KIM et al.American journal of hematology. 2012, Vol 87, Num 10, pp 961-968, issn 0361-8609, 8 p.Article

Genetic evidence of PEBP2β-independent activation of Runxl in the murine embryoYOKOMIZO, Tomomasa; YANAGIDA, Masatoshi; GANG HUANG et al.International journal of hematology. 2008, Vol 88, Num 2, pp 134-138, issn 0925-5710, 5 p.Article

Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemiaJOST, E; SCHMID, J; WILOP, S et al.British journal of haematology. 2008, Vol 142, Num 5, pp 745-753, issn 0007-1048, 9 p.Article

Histone Deacetylase Inhibitor Romidepsin Has Differential Activity in Core Binding Factor Acute Myeloid LeukemiaODENIKE, Olatoyosi M; ALKAN, Serhan; STIFF, Patrick et al.Clinical cancer research (Print). 2008, Vol 14, Num 21, pp 7095-7101, issn 1078-0432, 7 p.Article

Measurements of cerebral perfusion and arterial hemodynamics during visual stimulation using turbo-TILTHENDRIKSE, Jeroen; HANZHANG LU; VAN DER GROND, Jeroen et al.Magnetic resonance in medicine. 2003, Vol 50, Num 2, pp 429-433, issn 0740-3194, 5 p.Article

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemiasCARE, Rory S; VALK, Peter J. M; GOODEVE, Anne C et al.British journal of haematology. 2003, Vol 121, Num 5, pp 775-777, issn 0007-1048, 3 p.Article

Unlike AML1, CBFβ gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromesLEROY, Hugues; ROUMIER, Christophe; GRARDEL-DUFLOS, Nathalie et al.Blood. 2002, Vol 99, Num 10, pp 3848-3850, issn 0006-4971Article

Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 miceYAMASHITA, Namiko; OSATO, Motomi; LIQUN HUANG et al.British journal of haematology. 2005, Vol 131, Num 4, pp 495-507, issn 0007-1048, 13 p.Article

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemiaGOEMANS, B. F; ZWAAN, Ch. M; KASPERS, G. J. L et al.Leukemia. 2005, Vol 19, Num 9, pp 1536-1542, issn 0887-6924, 7 p.Article

Impact of Residual Normal Metaphases in Core Binding Factor Acute Myeloid LeukemiaMEDEIROS, Bruno C; OTHUS, Megan; MIN FANG et al.Cancer. 2012, Vol 118, Num 9, pp 2420-2423, issn 0008-543X, 4 p.Article

Intensifying daunorubicin in induction for patients with core binding factor leukemiaDOBASHI, Nobuaki; YAMAGUCHI, Yuko; ASAI, Osamu et al.International journal of hematology. 2006, Vol 84, Num 5, pp 463-464, issn 0925-5710, 2 p.Article

Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11SHIGESADA, Katsuya; VAN DE SLUIS, Bart; LIU, P. Paul et al.Oncogene (Basingstoke). 2004, Vol 23, Num 24, pp 4297-4307, issn 0950-9232, 11 p.Article

Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospectsGOYAMA, Susumu; MULLOY, James C.International journal of hematology. 2011, Vol 94, Num 2, pp 126-133, issn 0925-5710, 8 p.Article

KIT mutations confer a distinct gene expression signature in core binding factor leukaemiaLÜCK, Sonja C; RUSS, Annika C; JUAN DU et al.British journal of haematology. 2010, Vol 148, Num 6, pp 925-937, issn 0007-1048, 13 p.Article

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AMLPOLLARD, Jessica A; ALONZO, Todd A; WEINSTEIN, Howard J et al.Blood. 2010, Vol 115, Num 12, pp 2372-2379, issn 0006-4971, 8 p.Article

Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantationYOON, J.-H; KIM, H.-J; MIN, C.-K et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 12, pp 1466-1474, issn 0268-3369, 9 p.Article

Survival Is Poorer in Patients With Secondary Core-binding Factor Acute Myelogenous Leukemia Compared With De Novo Core-binding Factor LeukemiaBORTHAKUR, Gautam; LIN, E; JAIN, Nitin et al.Cancer. 2009, Vol 115, Num 14, pp 3217-3221, issn 0008-543X, 5 p.Article

Prognostic markers in AML: focus on CBFLCAIROLI, R; BEGHINI, A; TURRINI, M et al.Leukemia supplements (Print). 2012, Vol 1, Num 2, issn 2044-5210, S12-S13Conference Paper

Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemiasILLMER, Thomas; SCHAICH, Markus; EHNINGER, Gerhard et al.Haematologica (Roma). 2007, Vol 92, Num 1, pp 137-138, issn 0390-6078, 2 p.Article

Acceleration of G₁ cooperates with core binding factor β-smooth muscle myosin heavy chain to induce acute leukemia in miceYANDAN YANG; WEIHUA WANG; CLEAVES, Rebecca et al.Cancer research (Baltimore). 2002, Vol 62, Num 8, pp 2232-2235, issn 0008-5472Article